Cargando...
Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival
BACKGROUND: Widespread application of vascularized composite allotransplantation (VCA) is currently limited by the required lifelong systemic immunosuppression and its associated morbidity and mortality. This study evaluated the efficacy of ex vivo (after procurement but before transplantation) engi...
Guardado en:
| Publicado en: | Plast Reconstr Surg Glob Open |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6157929/ https://ncbi.nlm.nih.gov/pubmed/30276052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GOX.0000000000001825 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|